IGI Logo

The markets are expected to open marginally lower today as trends in GIFT NIFTY indicate a negative start for the broader index after NIFTY closed 92 points lower at 22,460 on Monday.

Anupam Rasayan:

The company signed a $106 million (?922 crore) 10-year LOI with a leading Korean MNC for high-performance niche chemical supply from FY26.

Ashoka Buildcon:

The company received an LoA from MSETCL for a ?311.92 crore project to establish a 400/220 KV substation and transmission lines in Maharashtra.

Bharat Electronics:

The company secured additional orders worth ?843 crore for RF seekers, vessel and air traffic management systems, radar upgrades, and services.

Godrej Consumer Products:

The company launched its first integrated greenfield plant in Chengalpattu, Tamil Nadu, with a ?515 crore investment over five years.

HEG:

The company’s associate Bhilwara Energy approved a fund raise of ?500 crore led by Singularity AMC to accelerate its energy transition businesses.

Hindustan Zinc:

The company approved issuing unsecured, redeemable, rated, listed NCDs of ?500 crore via private placement in three separately transferable and redeemable parts.

Infosys:

The company’s subsidiary Finacle implemented its Treasury solution for Chola, centralizing treasury management on a unified web-based platform to enhance trading, risk management, and operations.

MSTC:

The company received a work order from Coal India to act as an e-auction service provider for coal and coal products for two years.

Nazara Technologies:

The company’s subsidiary Nodwin Gaming extended a guarantee of EUR 1.56 million (~?14.73 crores) for Freaks 4U Gaming’s loan from FRE GmbH & Co. KG.

SJVN:

The company signed an MoU with Chhattisgarh Govt. and CSPGCL for a ?9,500 crore 1,800 MW Pumped Storage Project at Kotpali, Balrampur.

Sun Pharma:

The company will acquire Nasdaq-listed Checkpoint Therapeutics, strengthening its oncology portfolio with FDA-approved UNLOXCYT for advanced cutaneous squamous cell carcinoma treatment.

Syngene International:

The company approved an additional investment of $56 million in its wholly owned US subsidiary Syngene USA Inc for a biologics facility acquisition.

Please refer disclaimer at http://www.aretesecurities.com/

SEBI Regn. No.: INM0000127